Altropane I-123 Uses, Dosage, Side Effects and more
Altropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes).
| Trade Name | Altropane I-123 |
| Generic | Altropane I-123 |
| Type | |
| Formula | C18H21FINO2 |
| Weight | Average: 425.275 Monoisotopic: 425.061230027 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
